Frontiers in Cell and Developmental Biology (Sep 2021)

Tumor-Derived Exosomal Protein Tyrosine Phosphatase Receptor Type O Polarizes Macrophage to Suppress Breast Tumor Cell Invasion and Migration

  • Hongmei Dong,
  • Chaoyu Xie,
  • Yuchen Jiang,
  • Kai Li,
  • Yusheng Lin,
  • Yusheng Lin,
  • Yusheng Lin,
  • Xijiao Pang,
  • Xiao Xiong,
  • Jiehua Zheng,
  • Xiurong Ke,
  • Xiurong Ke,
  • Xiurong Ke,
  • Yexi Chen,
  • Yong Li,
  • Yong Li,
  • Yong Li,
  • Hao Zhang

DOI
https://doi.org/10.3389/fcell.2021.703537
Journal volume & issue
Vol. 9

Abstract

Read online

Tumor-derived exosomes, containing multiple nucleic acids and proteins, have been implicated to participate in the interaction between tumor cells and microenvironment. However, the functional involvement of phosphatases in tumor-derived exosomes is not fully understood. We and others previously demonstrated that protein tyrosine phosphatase receptor type O (PTPRO) acts as a tumor suppressor in multiple cancer types. In addition, its role in tumor immune microenvironment remains elusive. Bioinformatical analyses revealed that PTPRO was closely associated with immune infiltration, and positively correlated to M1-like macrophages, but negatively correlated to M2-like macrophages in breast cancer tissues. Co-cultured with PTPRO-overexpressing breast cancer cells increased the proportion of M1-like tumor-associated macrophages (TAMs) while decreased that of M2-like TAMs. Further, we observed that tumor-derived exosomal PTPRO induced M1-like macrophage polarization, and regulated the corresponding functional phenotypes. Moreover, tumor cell-derived exosomal PTPRO inhibited breast cancer cell invasion and migration, and inactivated STAT signaling in macrophages. Our data suggested that exosomal PTPRO inhibited breast cancer invasion and migration by modulating macrophage polarization. Anti-tumoral effect of exosomal PTPRO was mediated by inactivating STAT family in macrophages. These findings highlight a novel mechanism of tumor invasion regulated by tumor-derived exosomal tyrosine phosphatase, which is of translational potential for the therapeutic strategy against breast cancer.

Keywords